THOR Profile
Thoratec Corporation (THOR) was a medical device company that developed and marketed mechanical circulatory support products to treat heart failure. The company was acquired by St. Jude Medical, Inc. in 2015 and is no longer publicly traded.
Before the acquisition, THOR reported revenues of $455.5 million for the fiscal year ended December 28, 2013. The company reported a net income of $54.7 million for the same period.
Thoratec's growth strategy focused on expanding its product portfolio and increasing its geographic reach. The company's focus on developing innovative medical devices for heart failure patients enabled it to establish a strong presence in the medical device industry.
Investing in medical device companies like Thoratec carries market risks, including the risk of market volatility, regulatory hurdles, and competition from other medical device providers. Investors should carefully consider these risks before investing in THOR (now part of St. Jude Medical) and consult with a financial advisor to determine if it is an appropriate investment for their portfolio. They should also review the company's public disclosures and financial statements to gain a better understanding of its financial performance and risks.
|
